Brind.

Conestoga Capital Advisors highlighted Twist Bioscience in its investor letter on July 28, 2025.

1 report, 1 independent Updated Jul 28

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Twist Bioscience

Keep exploring

The entities involved

Twist Bioscience
Biotechnology company
- Analyst firm set price targets for Leerink partners' client, Twist Bioscience, on June 26, 2026. Concurrently, the CEO sold shares due to tax withholding obligations.Mon 08:52

Coverage

Newest first; wire copies grouped

Jul 28Insider MonkeyIs Twist Bioscience Corp. (TWST) Nearing Profitability? Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be download